Rocío Díaz Acedo (Rocío Díaz-Acedo)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Locally Advanced

Ankylosing Spondylitis

Atopic Dermatitis

Top Venues

International journal of clinical pharmacy

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Leukemia & lymphoma

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Isabel María Carrión-Madroñal, Rocío Díaz Acedo, Santiago José Lora-Escobar, Eloisa Naranjo-Llamas, Didiana Jaramillo-Ruiz, Silvia Artacho-Criado, Elena Prado-Mel
Sacituzumab-govitecan in metastatic triple-negative breast cancer: a multicenter effectiveness and safety study. Future oncology (London, England) (2024)
Rocío Díaz Acedo, Silvia Artacho Criado, Eduardo Ríos Herranz, Antonio Gutiérrez Pizarraya, Irene Sánchez Romero, Esther Márquez Saavedra
Hypogammaglobulinemia after front-line immunochemotherapy in patients with follicular lymphoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Rocío Díaz Acedo, Mercedes Galvan Banqueri, Silvia Artacho Criado, Eva María Fernández Parra, Rocío Jiménez Galán, Ana Isabel Gago Sánchez, Juan Francisco Marín Pozo, María José Martínez Bautista
Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer. International journal of clinical pharmacy 46 (2) (2023)
Rocío Díaz Acedo, Mercedes Galvan Banqueri, Silvia Artacho Criado, Eva María Fernández Parra, Rocío Jiménez Galán, Ana Isabel Gago Sánchez, Juan Francisco Marín Pozo, María José Martínez Bautista
Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer. International journal of clinical pharmacy 46 (2) (2023)
Rocío Díaz Acedo, Mercedes Galvan Banqueri, Silvia Artacho Criado, Eva María Fernández Parra, Rocío Jiménez Galán, Ana Isabel Gago Sánchez, Juan Francisco Marín Pozo, María José Martínez Bautista
Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer. International journal of clinical pharmacy (2023)
Rocío Díaz Acedo, María Ángeles Domínguez Muñoz, Clara Navajas Laguna, Rosario Morales Camacho, Isabel Simón Pilo, Virgilio Pablo Calama Ruiz-Mateos, Manuel Yébenes Ramírez, María Vahí Sánchez de Medina, Silvia Artacho Criado, Aitana Rodríguez Pérez, María Carmen Couto Caro
Tagraxofusp as first-line treatment for blastic plasmacytoid dendritic cell neoplasm. Leukemia & lymphoma 63 (7) (2022)
Rocío Díaz Acedo, Silvia Artacho Criado, Rocío Jiménez Galán, Antonio Gutiérrez Pizarraya, Mercedes Galván Banqueri, María Rodríguez-de-la-Borbolla-Artacho, José Antonio Marcos Rodríguez, Esther Márquez Saavedra
Effectiveness and safety of eribulin for human epidermal growth factor receptor 2 negative metastatic breast cancer in a real-world population. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Rocío Díaz Acedo, Mercedes Galvan Banqueri, Esther Márquez Saavedra
Indirect comparison of anti-interleukin 17 targeted biological treatments for moderate-to-severe psoriasis. Journal of clinical pharmacy and therapeutics 45 (4) (2020)